Building a Vaccine One Patient at a Time: NeoVax in an Early Ovarian Cancer StudyBy Sander OlsenOctober 16, 2026 A phase 1 study built NeoVax vaccines one patient at a time from tumour mutations and combined them with nivolumab. What the early results actually establish.
